MedTrace Logo

Side Effects of Pulmonary Hypertension Medications

NCT01571713 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-09-16

No results posted yet for this study

Summary

The study seeks to analyze the patient reported effects of pulmonary hypertension medications and compare these with the side effects described on the package inserts. Side effects for these PH medications have been described in the adult population, but have never been described in the pediatric population. This information can better improve patient care and be used to characterize the side effects resultant from these medications.

Conditions

  • Pulmonary Hypertension

Sponsors & Collaborators

Principal Investigators

  • Jeffrey Feinstein, MD, MPH · Stanford University

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571713 on ClinicalTrials.gov